BOTJ vs CARE vs JPM

For growth investors, Carter Bankshares, Inc.

(CARE) is the stronger pick with 6. 2% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). Bank of the James Financial Group, Inc. (BOTJ) offers the better valuation at 12. 4x trailing P/E, making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Bank of the James Financial Group, Inc.

(BOTJ) is the cheapest at 12. 4x versus Carter Bankshares, Inc. at 21. 3x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to +55. 8% for Bank of the James Financial Group, Inc. (BOTJ). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CARE's +141. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Bank of the James Financial Group, Inc.

(BOTJ) is the lower-risk stock at 0. 15β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 510% more volatile than BOTJ relative to the S&P 500. On balance sheet safety, Bank of the James Financial Group, Inc. (BOTJ) carries a lower debt/equity ratio of 11% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Carter Bankshares, Inc.

(CARE) is pulling ahead at 6. 2% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 15. 7% for CARE. At the gross margin level — before operating expenses — BOTJ leads at 77. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 5. 5x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.

In this comparison, JPM (1.

9% yield), BOTJ (1. 6% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Bank of the James Financial Group, Inc.

(BOTJ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 15), 1. 6% yield, +155. 2% 10Y return). Both have compounded well over 10 years (BOTJ: +155. 2%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BOTJ is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. BOTJ, JPM pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.